These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35411535)

  • 41. Physicians' Perspectives Regarding Prescription Drug Monitoring Program Use Within the Department of Veterans Affairs: a Multi-State Qualitative Study.
    Radomski TR; Bixler FR; Zickmund SL; Roman KM; Thorpe CT; Hale JA; Sileanu FE; Hausmann LRM; Thorpe JM; Suda KJ; Stroupe KT; Gordon AJ; Good CB; Fine MJ; Gellad WF
    J Gen Intern Med; 2018 Aug; 33(8):1253-1259. PubMed ID: 29520747
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An Interrupted Time-series Evaluation of the Association Between State Laws Mandating Prescriber Use of Prescription Drug Monitoring Programs and Discontinuation of Chronic Opioid Therapy in US Veterans.
    Arnold J; Zhao X; Cashy JP; Sileanu FE; Mor MK; Moyo P; Thorpe CT; Good CB; Radomski TR; Fine MJ; Gellad WF
    Med Care; 2021 Dec; 59(12):1042-1050. PubMed ID: 34670221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prescription History Before Opioid Overdose Death: PDMP Data and Responsible Prescribing.
    Shreffler J; Shaw I; Berrones A; Huecker M
    J Public Health Manag Pract; 2021 Jul-Aug 01; 27(4):385-392. PubMed ID: 32810066
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of Payor-Mandated Review of Prescription Drug Monitoring Program on Opioid Prescriber Rates.
    Schumann SO; Zhang J; McCauley JL; Heidari K; Ball SJ
    South Med J; 2020 Sep; 113(9):415-417. PubMed ID: 32885255
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prescribing Associated with High-Risk Opioid Exposures Among Non-cancer Chronic Users of Opioid Analgesics: a Social Network Analysis.
    Hinami K; Ray MJ; Doshi K; Torres M; Aks S; Shannon JJ; Trick WE
    J Gen Intern Med; 2019 Nov; 34(11):2443-2450. PubMed ID: 31420823
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-Risk Opioid Prescribing Trends: Prescription Drug Monitoring Program Data From 2010 to 2018.
    Ball SJ; Simpson K; Zhang J; Marsden J; Heidari K; Moran WP; Mauldin PD; McCauley JL
    J Public Health Manag Pract; 2021 Jul-Aug 01; 27(4):379-384. PubMed ID: 32956292
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Opioid Prescribing Patterns and Patient Outcomes by Prescriber Type in the Oregon Prescription Drug Monitoring Program.
    Fink PB; Deyo RA; Hallvik SE; Hildebran C
    Pain Med; 2018 Dec; 19(12):2481-2486. PubMed ID: 29155988
    [TBL] [Abstract][Full Text] [Related]  

  • 48. State-level prescription drug monitoring program mandates and adolescent injection drug use in the United States, 1995-2017: A difference-in-differences analysis.
    Earlywine JJ; Hadland SE; Raifman J
    PLoS Med; 2020 Sep; 17(9):e1003272. PubMed ID: 32976539
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of a Mandatory Prescription Drug Monitoring Program on Prescription of Opioid Analgesics by Dentists.
    Rasubala L; Pernapati L; Velasquez X; Burk J; Ren YF
    PLoS One; 2015; 10(8):e0135957. PubMed ID: 26274819
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of targeted insurer-mandated prescription monitoring on opioid prescribing patterns.
    Fleming JN; Zhang J; Taber DJ; McCauley JL; Schumann S; Mauldin PD; Ball S
    J Am Pharm Assoc (2003); 2020; 60(4):559-564. PubMed ID: 32033899
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estimating the Direct Costs of Outpatient Opioid Prescriptions: A Retrospective Analysis of Data from the Rhode Island Prescription Drug Monitoring Program.
    Aroke H; Buchanan A; Wen X; Ragosta P; Koziol J; Kogut S
    J Manag Care Spec Pharm; 2018 Mar; 24(3):214-224. PubMed ID: 29485950
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Impact of Prescription Drug Monitoring Programs and Prescribing Guidelines on Emergency Department Opioid Prescribing: A Multi-Center Survey.
    Pomerleau AC; Nelson LS; Hoppe JA; Salzman M; Weiss PS; Perrone J
    Pain Med; 2017 May; 18(5):889-897. PubMed ID: 26995800
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of a State Opioid Prescribing Limit and Electronic Medical Record Alert on Opioid Prescriptions: a Difference-in-Differences Analysis.
    Lowenstein M; Hossain E; Yang W; Grande D; Perrone J; Neuman MD; Ashburn M; Delgado MK
    J Gen Intern Med; 2020 Mar; 35(3):662-671. PubMed ID: 31602561
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Change in Postoperative Opioid Prescribing Patterns for Oculoplastic and Orbital Procedures Associated With State Opioid Legislation.
    Xie Y; Joseph AW; Rudy SF; Elner VM; Demirci H; Kim DS; Nelson CC; Joseph SS
    JAMA Ophthalmol; 2021 Feb; 139(2):157-162. PubMed ID: 33300973
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association Between Prescription Drug Monitoring Program Use Mandate and Opioid Prescribing and Patient-Reported Outcomes After Surgery.
    Chua KP; Nguyen TD; Brummett CM; Bohnert AS; Gunaseelan V; Englesbe MJ; Lee S; Waljee JF
    Ann Surg; 2024 May; ():. PubMed ID: 38716667
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of state-level prescription drug monitoring program implementation with opioid prescribing transitions in primary care in Australia.
    Xia T; Picco L; Buchbinder R; Haas R; Nielsen S
    Br J Clin Pharmacol; 2024 Apr; 90(4):1162-1172. PubMed ID: 38308463
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Opioid e-prescribing trends at discharge in a large pediatric health system.
    Horvat CM; Martin B; Wu L; Fabio A; Empey PE; Hagos F; Bigelow S; Kantawala S; Au AK; Kochanek PM; Clark RSB
    J Opioid Manag; 2019; 15(2):119-127. PubMed ID: 31343713
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.
    Lee B; Zhao W; Yang KC; Ahn YY; Perry BL
    JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Query mandates in prescription drug monitoring programs reduce opioid use among commercially insured patients with cancer.
    Le TT; Fleming SP; Kuzucan A; Dizik A; Simoni-Wastila L
    J Am Pharm Assoc (2003); 2022; 62(1):363-369. PubMed ID: 34246576
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of trends in opioid dispensing patterns between Medicaid pharmacy claims and prescription drug monitoring program data.
    El Ibrahimi S; Hallvik S; Johnston K; Leichtling G; Choo E; Hartung DM
    Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1168-1174. PubMed ID: 32939909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.